Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Bright Minds Biosciences Inc. (DRUG) had Debt to Equity Ratio of 0.02 for the most recently reported fiscal year, ending 2024-09-30.
| Income Statement Financials | |
-- |
|
$-2.06M |
|
-- |
|
-- |
|
$2.07M |
|
$-2.07M |
|
$0.02M |
|
$-2.06M |
|
$-2.06M |
|
$-2.06M |
|
$-2.06M |
|
$-2.06M |
|
$-2.06M |
|
$-2.07M |
|
$-2.02M |
|
4.31M |
|
4.31M |
|
$-0.48 |
|
$-0.48 |
|
| Balance Sheet Financials | |
$4.40M |
|
-- |
|
$0.09M |
|
$4.49M |
|
$0.39M |
|
$0.03M |
|
$0.03M |
|
$0.42M |
|
$4.07M |
|
$4.07M |
|
$4.07M |
|
4.52M |
|
| Cash Flow Statement Financials | |
$-1.36M |
|
-- |
|
$0.60M |
|
$4.96M |
|
$4.20M |
|
$-0.76M |
|
$0.62M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.32 |
|
-- |
|
-- |
|
0.01 |
|
|
Debt to Equity Ratio |
0.02 |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.36M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-50.61% |
|
-50.61% |
|
-45.90% |
|
-50.25% |
|
$0.90 |
|
$-0.32 |
|
$-0.32 |
|